What question did this study set out to answer?

To evaluate the diagnostic accuracy, therapeutic impact, and utility of 18FDG-PET in diagnosing primary or recurrent pancreatic adenocarcinoma and monitoring response to neoadjuvant chemoradiation.

May 1, 1999Annals of SurgeryOpen Access

18Fluorodeoxyglucose-Positron Emission Tomography in the Management of Patients With Suspected Pancreatic Cancer

View Full Paper

Ask AI

Bookmark

Authors

DRDavid M. RoseEglin Air Force Base DDDominique DelbekeVanderbilt University Medical Center RBR. Daniel BeauchampVanderbilt University Medical Center

Discussion

Member takes

Implication

Retrospective study reveals superior diagnostic accuracy of 18FDG-PET over CT in suspected pancreatic adenocarcinoma, indicating significant potential to optimize clinical management decisions.

Key Points

To evaluate the diagnostic accuracy, therapeutic impact, and utility of 18FDG-PET in diagnosing primary or recurrent pancreatic adenocarcinoma and monitoring response to neoadjuvant chemoradiation.
Evaluated 81 18FDG-PET scans across 70 patients, comprising 65 evaluated for suspected primary tumors, 9 scanned before and after neoadjuvant chemoradiation, and 8 evaluated for suspected post-resection recurrence.
Analyzed scans visually and semiquantitatively using the standard uptake ratio, comparing diagnostic sensitivity and specificity against conventional computed tomography (CT).
For primary tumor diagnosis among 65 patients, 18FDG-PET demonstrated higher sensitivity (92% vs. 65%) and specificity (85% vs. 62%) than CT.
18FDG-PET clarified indeterminate or unrecognized CT findings in 28% of primary masses and 11% of metastases, altering clinical management in 43% (28/65) of primary tumor cases.
In 9 neoadjuvant therapy patients, 18FDG-PET identified tumor regression in 4, stable disease in 3, and progression in 2 where CT showed no response; it also confirmed recurrence in all 8 post-resection patients.

Cite This Study

Rose et al. (1999) studied this question.

synapsesocial.com/papers/6aab415d9a2af5a4150fba5f https://doi.org/10.1097/00000658-199905000-00016

View Full Paper

Ask AI

Bookmark

May 1, 1999Annals of SurgeryOpen Access

18Fluorodeoxyglucose-Positron Emission Tomography in the Management of Patients With Suspected Pancreatic Cancer

View Full Paper

Ask AI

Bookmark

Authors

DRDavid M. RoseEglin Air Force Base DDDominique DelbekeVanderbilt University Medical Center RBR. Daniel BeauchampVanderbilt University Medical Center

Discussion

Member takes

Implication

Retrospective study reveals superior diagnostic accuracy of 18FDG-PET over CT in suspected pancreatic adenocarcinoma, indicating significant potential to optimize clinical management decisions.

Key Points

To evaluate the diagnostic accuracy, therapeutic impact, and utility of 18FDG-PET in diagnosing primary or recurrent pancreatic adenocarcinoma and monitoring response to neoadjuvant chemoradiation.
Evaluated 81 18FDG-PET scans across 70 patients, comprising 65 evaluated for suspected primary tumors, 9 scanned before and after neoadjuvant chemoradiation, and 8 evaluated for suspected post-resection recurrence.
Analyzed scans visually and semiquantitatively using the standard uptake ratio, comparing diagnostic sensitivity and specificity against conventional computed tomography (CT).
For primary tumor diagnosis among 65 patients, 18FDG-PET demonstrated higher sensitivity (92% vs. 65%) and specificity (85% vs. 62%) than CT.
18FDG-PET clarified indeterminate or unrecognized CT findings in 28% of primary masses and 11% of metastases, altering clinical management in 43% (28/65) of primary tumor cases.
In 9 neoadjuvant therapy patients, 18FDG-PET identified tumor regression in 4, stable disease in 3, and progression in 2 where CT showed no response; it also confirmed recurrence in all 8 post-resection patients.

Cite This Study

Rose et al. (1999) studied this question.

synapsesocial.com/papers/6aab415d9a2af5a4150fba5f https://doi.org/10.1097/00000658-199905000-00016

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark